HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Treatment of aspiration or tracheostomy-associated pneumonia in neurologically impaired children: effect of antimicrobials effective against anaerobic bacteria.

AbstractThe purpose of the present study was to retrospectively review the antibiotic therapy of aspiration or tracheostomy-associated pneumonia in 57 neurologically impaired children (NIC). The antimicrobials used were either ticarcillin-clavulanate or clindamycin, which are effective against penicillin-resistant anaerobic bacteria, or ceftriaxone, which is less effective against these organisms. In those with aspiration pneumonia, a satisfactory clinical and microbiological response was observed in 8/9 (89%) patients who received ticarcillin-clavulanate, and 10/11 (91%) who received clindamycin with or without ceftazidime, as compared to 7/14 (50%) who received ceftriaxone (P < 0.05). For those who experienced tracheostomy-associated pneumonia, a positive response to therapy was observed in 5/6 (83%) who received ticarcillin-clavulanate, and 7/7 (100%) who received clindamycin with or without ceftazidime, as opposed to 4/10 (40%) who were treated with ceftriaxone (P < 0.05). The duration of fever was longer in both cases for those who received ceftriaxone. To summarize, this study illustrates the superiority of antimicrobials effective against penicillin-resistant anaerobic bacteria, as compared to an antibiotic without such coverage, in the therapy of aspiration or tracheostomy-associated pneumonia in NIC.
AuthorsI Brook (Affiliation: Department of Pediatrics, Georgetown University School of Medicine, Washington, DC, USA.)
JournalInternational journal of pediatric otorhinolaryngology (Int J Pediatr Otorhinolaryngol) Vol. 35 Issue 2 Pg. 171-7 (Apr 1996) ISSN: 0165-5876 [Print] IRELAND
PMID8735413 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Cephalosporins
  • Clavulanic Acids
  • Penicillins
  • Clindamycin
  • Ticarcillin
  • Clavulanic Acid
  • Ceftriaxone
  • Ceftazidime
Topics
  • Adolescent
  • Anti-Bacterial Agents (administration & dosage, therapeutic use)
  • Bacteria, Anaerobic (drug effects)
  • Bacterial Infections (drug therapy)
  • Ceftazidime (administration & dosage, therapeutic use)
  • Ceftriaxone (administration & dosage, therapeutic use)
  • Cephalosporins (administration & dosage, therapeutic use)
  • Child
  • Child, Preschool
  • Clavulanic Acid
  • Clavulanic Acids (administration & dosage, therapeutic use)
  • Clindamycin (administration & dosage, therapeutic use)
  • Female
  • Fever (drug therapy)
  • Humans
  • Male
  • Penicillins (administration & dosage, therapeutic use)
  • Pneumonia, Aspiration (drug therapy, microbiology)
  • Pneumonia, Bacterial (drug therapy, etiology)
  • Retrospective Studies
  • Seizures (complications)
  • Ticarcillin (administration & dosage, therapeutic use)
  • Tracheostomy (adverse effects)
  • Unconsciousness (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD